At the forefront of innovation, compounding pharmacies are reshaping healthcare by providing tailored, patient-centric solutions. With a $6B market poised for 6.1% annual growth, the sector addresses critical gaps in medication shortages, rising drug costs, and the demand for personalized medicine.
What you'll learn:
- The Market potential with room for consolidation and scaling
- Growth drivers for the industry
- Private equity opportunities for investing
Whether you're an investor, a healthcare provider, or a patient, compounding pharmacies offer a unique opportunity to create impactful change in the pharmaceutical landscape.
Download the Report
Alvarez & Marsal Invests in Life Sciences, Adds Eduardo Schur to Lead Business
September 23, 2026
Mr. Schur joins A&M to accelerate the growth of its Life Sciences Strategic Business Unit as companies face rising pressure across clinical development, product launches, and market access.
Alvarez & Marsal Invests in Life Sciences, Adds Eduardo Schur to Lead Business
September 23, 2026
Mr. Schur joins A&M to accelerate the growth of its Life Sciences Strategic Business Unit as companies face rising pressure across clinical development, product launches, and market access.
Alvarez & Marsal Invests in Life Sciences, Adds Eduardo Schur to Lead Business
September 23, 2026
Mr. Schur joins A&M to accelerate the growth of its Life Sciences Strategic Business Unit as companies face rising pressure across clinical development, product launches, and market access.
Alvarez & Marsal Invests in Life Sciences, Adds Eduardo Schur to Lead Business
September 23, 2026
Mr. Schur joins A&M to accelerate the growth of its Life Sciences Strategic Business Unit as companies face rising pressure across clinical development, product launches, and market access.